ABBOTT LABORATORIES — Director's Dealing 2007

Jan 6, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-01-04

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-01-04	Common shares without par value	M	1617	$26.8783	Acquired	38619	Direct
2007-01-04	Common shares without par value	S	1617	$50.00	Disposed	37002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-01-04	Option (right to buy)	$26.8783	M	1617	Disposed	2007-03-30	common shares (1617)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1697	Indirect
Common shares without par value	724	Indirect

Footnotes

F1: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F2: The reporting person disclaims beneficial ownership of all securities held by her husband.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.